These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15493117)
21. The role of lead in renal failure. Wedeen RP Clin Exp Dial Apheresis; 1982; 6(2-3):113-46. PubMed ID: 6758998 [TBL] [Abstract][Full Text] [Related]
22. ["Podagric kidney" accompanied by development of chronic renal insufficiency]. Saltykov BB Arkh Patol; 1975; 37(9):65-7. PubMed ID: 1227465 [No Abstract] [Full Text] [Related]
23. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy]. Orfanos CE; Künzig M Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845 [TBL] [Abstract][Full Text] [Related]
24. Lead nephropathy. Wedeen RP; D'Haese P; Van de Vyver FL; Verpooten GA; De Broe ME Am J Kidney Dis; 1986 Nov; 8(5):380-3. PubMed ID: 3098095 [TBL] [Abstract][Full Text] [Related]
25. Patterns of lead excretion in patients with gout and chronic renal failure--a comparative German and Australian study. Craswell PW; Price J; Boyle PD; Behringer D; Stoeppler M; Ritz E Sci Total Environ; 1987 Oct; 66():17-28. PubMed ID: 3120309 [TBL] [Abstract][Full Text] [Related]
26. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy. Wedeen RP Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486 [TBL] [Abstract][Full Text] [Related]
27. Elevated lead burden in Chinese patients without occupational lead exposure. Lin JL; Lim PS Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500 [TBL] [Abstract][Full Text] [Related]
28. Update on gout and hyperuricemia. Baker JF; Schumacher HR Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378 [TBL] [Abstract][Full Text] [Related]
29. Chronic lead nephropathy in Queensland: alternative methods of diagnosis. Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW; Williams GM Aust N Z J Med; 1986 Feb; 16(1):11-9. PubMed ID: 3085647 [TBL] [Abstract][Full Text] [Related]
30. Hyperuricemia and gout: new concepts in diagnosis and management. Doghramji PP; Wortmann RL Postgrad Med; 2012 Nov; 124(6):98-109. PubMed ID: 23322143 [TBL] [Abstract][Full Text] [Related]
31. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial. Lin JL; Ho HH; Yu CC Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856 [TBL] [Abstract][Full Text] [Related]
32. Nephropathy in chronic lead poisoning. Morgan JM; Hartley MW; Miller RE Arch Intern Med; 1966 Jul; 118(1):17-29. PubMed ID: 5940188 [No Abstract] [Full Text] [Related]
33. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. Lin JL; Lin-Tan DT; Hsu KH; Yu CC N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640 [TBL] [Abstract][Full Text] [Related]
34. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate. Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562 [TBL] [Abstract][Full Text] [Related]
35. [Pathogenesis, diagnostics and therapy of gout]. Zurek M Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617 [TBL] [Abstract][Full Text] [Related]